Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128841) titled 'Single-Cell Transcriptomic Profiling of Heterogeneous Treatment Responses to Combined Radiotherapy and Immunotherapy in Stage III-IVA Locally Advanced Cervical Cancer' on July 27.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Stage III-IVA Locally Advanced Cervical Cancer
Intervention:
Patients with locally advanced cervical cancer (Stage III-IV) planned for combined radiotherapy and anti-PD-1 immunotherapy.:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample S...